Skandinaviska Enskilda Banken (SEB)’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-4,100
Closed -$124K 1065
2021
Q2
$124K Hold
4,100
﹤0.01% 976
2021
Q1
$104K Hold
4,100
﹤0.01% 1046
2020
Q4
$101K Buy
+4,100
New +$77K ﹤0.01% 1048
2017
Q3
Sell
-3,698
Closed -$223K 740
2017
Q2
$223K Hold
3,698
﹤0.01% 731
2017
Q1
$257K Hold
3,698
﹤0.01% 714
2016
Q4
$247K Sell
3,698
-1,002
-21% -$65.2K ﹤0.01% 618
2016
Q3
$311K Hold
4,700
﹤0.01% 658
2016
Q2
$340K Hold
4,700
﹤0.01% 657
2016
Q1
$304K Hold
4,700
﹤0.01% 666
2015
Q4
$337K Buy
+4,700
New +$348K ﹤0.01% 586

Other funds holding MD

Skandinaviska Enskilda Banken (SEB)'s MD Position: Q3 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Pediatrix Medical (MD) in Q3 2021, closing a stake of 4,100 shares — an estimated $124K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MD in Q4 2015 and held it in 10 quarters. The position peaked at $340K in Q2 2016. 220 funds tracked by Wall St. Rank hold MD as of Q3 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Pediatrix Medical position as of Q3 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 4,100 Pediatrix Medical shares in Q3 2021, an estimated $124K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Pediatrix Medical in Q4 2015 and held it in 10 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Pediatrix Medical position peaked at $340K in Q2 2016.
  • 220 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2021, filed 10 Nov 2021.